Jun 29 | 14:26 IST
GST impact: Medicines for diabetes, cancer to get cheaper under new tax system
GST impact: Medicine shortage unlikely
Ahead of Modi visit, US lawmakers ask govt to rethink price cap on stents
US bans imports of drug from three Ipca Lab facilities; shares fall
Diabetes becoming a killer disease for India's urban poor: ICMR study
Sun Pharma receives USFDA nod for anti-cholesterol drug
Sun Pharma recalls 13,200 bottles of chewable Cetirizine in US
Over 8 lakh chemist shops go on nationwide strike over online pharmacies plan
Sun Pharma says 2018 sales may fall as US market gets tougher
GST rates unlikely to impact medicine prices as life saving drugs get marked in in low tax basket
Medtech companies edifying healthcare beyond device use
Global med-tech firms, India locked in tussle after stent price sting
USFDA issues warning letter to Divis Labs for Vizag unit
Mahindra Partners forays into healthcare
Divis's Labs stock hits a 52-week low following USFDA import alert on key unit
Sun Pharma's Mohali plant gets a breather; all eyes now on Halol
Govt receives Rs 672-cr fine from pharma firms for overcharging
Dr Reddy's gets 13 observations after USFDA inspection of its oncology formulation plant
NPPA's 'suspicion' of drug overpricing upsets industry
Lupin gets USFDA nod to market cancer drug
Cipla bets on respiratory, oncology and HIV segments in Brazil and China
USFDA concludes inspection of Dr Reddy's Miryalaguda facility
India's NRA for medicines is lauded by WHO
Indian pharma asks US to exclude India from list of IPR offenders
Piramal Enterprises acquires Mallinckrodt's pharma products for $203 million
Clove Dental announces big plans to expand chain of dental clinics
Abbott to make India hub of global research and development for branded generics
Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm
Outlook for pharma, education and microfinance in 2017
Sun Pharma arm picks up 14.6 per cent stake in US company for $13 mn